Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer's disease

Comparison of ultrasensitive and mass spectrometry quantification

Promising Blood Biomarkers for Clinical Use in Alzheimer's Disease

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary

Transitioning from cerebrospinal fluid to blood tests to

Boxplots of raw plasma biomarker levels for amyloid PET

Correlations of amyloid-β concentrations between CSF and plasma in

IJMS, Free Full-Text

β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer's disease and predicts cerebral amyloidosis, Alzheimer's Research & Therapy

Blood‐based biomarkers for Alzheimer's disease